the 305 Hospital Independent Scientific Research Fund,2024,No.24ZZJJLW-022.
BACKGROUND To assess the effectiveness of Shugan Jieyu capsules on peripheral blood miR-124,miR-132,and brain-derived neurotrophic factor(BDNF)levels in patients with mild to moderate depression following coronary art...
financially supported by the National Natural Science Foundation of China(No.82170701).
Objective This study aimed to analyze the clinical efficacy of the Jianpi Shengxue tablet for treating renal anemia.Methods A total of 200 patients with renal anemia from December 2020 to December 2022 were enrolled a...
Objective To observe the clinical efficacy of acupotomy combined with metformin hydrochloride tablet for type 2 diabetes mellitus(T2DM)and its effect on serum levels of inflammatory factors.Methods A total of 68patien...
Supported by the National Natural Science Foundation of China,No.81904175;Chongqing Health Planning Commission Project,No.ZY201802063,No.2019ZY013111,No.2022QNXM061;Chongqing Performance Incentive Project,No.jxyn2021-1-1;Chongqing Technology Innovation and Application Development Special Key Project,No.CSTB2022TIAD-KPX0187.
BACKGROUND The Correa sequence,initiated by Helicobacter pylori(H.pylori),commonly progresses to gastric cancer through the stage of chronic atrophic gastritis(CAG).Although eradication of H.pylori only reduces the ri...
Objective:To investigate the therapeutic effect of Biling Weitong Granules combined with oryz-aspergillus enzyme and pancreatin tablets on patients with reflux esophagitis with functional dyspepsia.Methods:Sixty patie...
Supported by National Natural Science Foundation of China,No.81930110;The National Funded Postdoctoral Researcher Program of China,No.GZC20232406;Henan Province Traditional Chinese Medicine Science Research Project,No.2023ZY3040;Henan Province Medical Science and Technology Research Plan Joint Construction Project,No.LHGJ20230233;National Key Research and Development Program of China,No.2022YFC2303103.
BACKGROUND Liuweiwuling Tablet(LWWL)is a Chinese patent medicine approved for the treatment of chronic inflammation caused by hepatitis B virus(HBV)infection.Previous studies have indicated an anti-HBV effect of LWWL,...
supported by the National Natural Science Foundation of China(Nos.82192912,82074273);the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(No.ZYYCXTD-C-202009);the Program of State Key Laboratory of Drug Research(No.SIMM2103ZZ-06).
Compound Shenhua Tablet,a medicine comprising seven herbs,is employed in treating IgA nephropathy.This study aimed to meticulously analyze its chemical composition.Based on a list of candidate compounds,identified thr...
sponsored and funded by Jiangsu Simcere Pharmaceutical(No.SIM1911);National Key R&D Program of China(Grant No.2022YFA1303000).
Background and purpose Clinical studies have demonstrated that edaravone dexborneol can improve the functional outcomes in patients with acute ischaemic stroke(AIS).The present clinical trial aimed at testing the effi...
support of Taiyuan Institute of Technology Scientific Research Initial Funding,China(Grant No.:2022KJ058);the Basic Research Project of Shanxi Province,China(Project No.:202203021212331);the Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi,China(Program Nos.:2022L529 and 2022L532);the Fund for Shanxi“1331”Project,China.
6-mercaptopurine(6-MP),a purine derivative(3,7-dihydropurine-6-thione),has been utilized as an effective immunosuppressive drug for clinically treating leukemia and other autoimmune diseases[1].6-MP and its correspond...